Clinical trials are a cornerstone of medical R&D, a wellspring of jobs, revenues and a way to provide more cutting-edge treatments to patients in desperate need. The KAIMRC/MNG-HA team is drawing inspiration and guidance from the clinical research success story of South Korea. In less than 10 years South Korea has transformed its unexceptional clinical trials profile into that of a world leader mainly through KoNECT (the Korea National Enterprise for Clinical Trials) that is now a close partner to the KAIMRC/MNG-HA clinical trials initiative.